You just read:

Intarcia and Calibr Announce Collaboration and In-Licensing Deal Aimed at Delivering a Next Generation Combination Product for Diabetes and Obesity

News provided by

Intarcia Therapeutics, Inc.

09 Jan, 2017, 09:00 ET